The Medical Advisor

Ivermectin Resources Recently, I have seen tremendous demand for some sort of initial guidance “WHERE TO START” with High Dose Ivermectin for CANCER. Editor's Note: Dr Makis proposes four distinct cancer protocols for using Ivermectin in cancer treatment, specifically for patients who have developed turbo cancer or aggressive cancers. These protocols, referred to as the “Dr. Makis Ivermectin Cancer Protocols,” are categorized based on dosage and the severity of the cancer. Updated version I have an article and a video that go into depth: June 10, 2024 - "15 minutes with Dr.Makis" - Episode 018: High Dose Ivermectin and Cancer .  2025 studies on ivermectin for cancer Yuan Yuan et al (Cedars-Sinai Medical Center) - A phase I/II study evaluating the safety and efficacy of ivermectin in combination with balstilimab in patients with metastatic triple negative breast cancer (ASCO 2025) Yuwen et al -  A Review of Ivermectin Use in Cancer Patients: Is it Time to Repurpose the Ive...

Semaglutide, known by the brand names Ozempic, Wegovy, Rybelsus and others, is the latest weight-loss craze to hit Hollywood and beyond. The prescription drug, which is administered via a weekly injection, is intended to treat Type 2 diabetes, but it’s widely used off-label for weight loss. They all belong to the same medication class — glucagon-like peptide-1 (GLP-1) agonists ( GLP-1 receptor agonists ).  GLP-1 agonists work by triggering insulin release, blocking sugar production in your liver, and making you feel full. But with all of these brands out there, how do you decide which is right for you? Let’s get to know some of the differences between these major GLP-1 agonist drugs. A 2021 study funded by Novo Nordisk, the drug’s maker, found using semaglutide once a week led to a 14.9% reduction in body weight among adults with obesity. 1  There’s been such a rush on the drugs that the U.S. Food and Drug Administratio...

The Missing Piece in the GLP-1 Puzzle That No One Is Talking About (Yet) Everyone is chasing injectable GLP-1 drugs like semaglutide (Ozempic, Wegovy) and tirzepatide for weight loss and diabetes control. But your body already has a built-in GLP-1 system — and it’s controlled, in part, by a fat-soluble vitamin most people have never heard of: vitamin K2 (menaquinone). New research (2022–2025) reveals a fascinating triangle: Gut Microbiome → Vitamin K2 → Endogenous GLP-1 Secretion When this triangle is working, you naturally produce more of your own GLP-1 — the same “satiety hormone” that the blockbuster drugs mimic. The result? Better blood sugar, reduced appetite, and easier fat loss — without weekly injections. Here’s exactly how it works, backed by the latest science. 1. Your Gut Bacteria Literally Manufacture Vitamin K2 Not all vitamin K is the same. Vitamin K1 (phylloquinone) comes from leafy greens and is mostly used for blood clotting. Vitamin K2 (menaquinones, especially MK-4 ...